Dare Bioscience, Inc. (DARE)
NGM · Common · CUSIP 23666P101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for DARE and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
23666P101 (prev. 15708Q105 )
Market Cap
Small Cap
IPO
4/10/2014 · $7.00/share
Previous Symbol
CERU (changed 7/20/2017)
Previous Name
Cerulean Pharma, Inc.
Business: Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.
Notes: July 20, 2017 -- Cerulean Pharma Inc. (CERU) will effect a one-for-ten (1-10) reverse split and change of name to Dare Bioscience, Inc. (DARE). The changes will become effective at the opening of business on 7/20,. In conjunction with the reverse split and change of name, the CUSIP number will change to 23666P101.

Company Contact

CEO
Sabrina Martucci Johnson
CFO
Lisa Walters-Hoffert
Headquarters
3655 Nobel Drive, Suite 260, San Diego, CA 92122
Phone
858-926-7655
Investor Relations
Daré Bioscience · 212-213-0006 · innovations@darebioscience.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »